PMID: 59181Jul 17, 1976

Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning

L F PrescottA T Proudfoot


60 patients with paracetamol poisoning have been treated with intravenous cysteamine, L-methionine, or D-penicillamine and the incidence and severity of hepatic necrosis compared with those observed in 70 patients receiving supportive therapy only. Of 31 patients with 4-hour plasma-paracetamol concentrations greater than 250 mug/ml given supportive therapy 22 sustained severe liver damage, 3 died in hepatic failure, and 4 developed acute renal failure. None of 23 similarly poisoned patients given cysteamine within 10 hours of ingestion suffered severe liver damage or renal failure and none died. Cysteamine was partially effective at 10-12 hours, but ineffective 12 hours or more after ingestion. Liver damage was absent or mild in 17 patients given L-methionine within 10-12 hours of ingestion but severe in 3 treated within 10 hours. Of 5 patients treated with D-penicillamine, 1 developed severe liver damage with acute renal failure. It is concluded that cysteamine prevents severe liver damage after paracetamol poisoning if given within 10 hours in adequate dosage.


Jan 1, 1982·European Journal of Drug Metabolism and Pharmacokinetics·S J HartJ D Tange
Jan 1, 1991·European Journal of Drug Metabolism and Pharmacokinetics·H Lew, A Quintanilha
Nov 14, 1983·The American Journal of Medicine·B H Rumack
Jul 25, 1991·Biochemical Pharmacology·W M NazarethA E McLean
Jan 18, 1982·Life Sciences·T M BadgerP Rosenblum
Oct 1, 1993·Pharmacology & Therapeutics·S H Thomas
Aug 30, 1985·Biochimica Et Biophysica Acta·C G Ostenson, S Efendić
Mar 1, 1986·Brain Research Bulletin·S M WebbR J Reiter
Oct 30, 1976·Lancet·J R Brouwers, P Vermeij
Jan 3, 1981·Lancet·C S Goodwin
Jan 3, 1981·Lancet·J M Smith, A A Gilbertson
Feb 8, 1986·Lancet·L G TeeD S Davies
May 1, 1978·JACEP·R G Peterson, B H Rumack
May 3, 2003·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·M RazaO A Al-Shabanah
Jan 20, 1977·The New England Journal of Medicine·L LyonsA M Sommaripa
Mar 3, 1977·The New England Journal of Medicine·R G Peterson, B H Rumack
Jul 19, 2008·The New England Journal of Medicine·Kennon J Heard
Jan 1, 1995·The British Journal of Nutrition·V ColombJ F Lemeland
Aug 1, 1991·British Journal of Clinical Pharmacology·A Penna, N Buchanan
Feb 11, 1978·British Medical Journal·J M SmithA A Gilbertson
Apr 1, 1978·British Medical Journal·L F PrescottA T Proudfoot
May 6, 1978·British Medical Journal·T J MeredithR Goulding
Aug 21, 1976·British Medical Journal·P CromeP Widdop
Sep 10, 1977·British Medical Journal·M J FordN D Finlayson
Nov 18, 1978·British Medical Journal·L F PrescottA T Proudfoot
Nov 3, 1979·British Medical Journal·L F PrescottA T Proudfoot
Feb 6, 1982·British Medical Journal·L F PrescottR J Cregeen
Feb 14, 1980·Nursing Mirror·S Hopkins
Apr 1, 1983·The Journal of Clinical Investigation·B H LauterburgJ R Mitchell
Oct 1, 1977·Journal of Clinical Pharmacology·P L Madan
Feb 23, 2012·BMC Clinical Pharmacology·S M D K Ganga SenarathnaRohini Fernandopulle
Aug 20, 1977·British Medical Journal
Jan 1, 1994·Journal of Toxicology. Clinical Toxicology·G R BondC Taylor
Mar 3, 2004·Emergency Medicine·Duncan Reid, Wayne Hazell
Feb 11, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·B H Rumack, D Nicholas Bateman
Mar 12, 2013·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·S GosselinJ Caro
Jan 1, 1987·Critical Reviews in Toxicology·A A Horton, S Fairhurst
Jan 1, 1978·Drug Metabolism Reviews·J F WinchesterW J Tilstone
May 1, 1978·The Journal of Pediatrics·A G Nogen, J E Bremner
Oct 1, 1991·Annals of Emergency Medicine·M J SmilksteinB H Rumack
Jan 1, 1986·The American Journal of the Medical Sciences·P M CopelandE C Ridgway
Jan 1, 1988·Human Toxicology·N A MintonR J Frankel
Aug 1, 1984·Human Toxicology·A T Proudfoot
Feb 24, 2018·The Cochrane Database of Systematic Reviews·Angela L ChiewNick A Buckley
Dec 1, 2012·Therapeutic Advances in Drug Safety·W Stephen Waring
Apr 1, 1983·Journal of Applied Toxicology : JAT·M C Savides, F W Oehme
Mar 1, 1988·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·J R BalesR Williams
Jan 22, 2008·Biomedical Chromatography : BMC·Krzysztof Kuśmierek, Edward Bald
Feb 1, 1984·Australian and New Zealand Journal of Medicine·M SegasothyA B Suleiman
Jul 22, 2008·British Journal of Clinical Pharmacology·R E Ferner
Apr 21, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Julie PolsonAmerican Association for the Study of Liver Disease
Jul 11, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·E Kozer, G Koren
Jul 13, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Eran Kozer, Michael McGuigan
Apr 21, 2006·The Cochrane Database of Systematic Reviews·J BrokC Gluud
Nov 1, 1987·Medical Toxicology and Adverse Drug Experience·A A Lawson, D B Northridge
Jul 26, 2019·Toxicology Research·D Nicholas Bateman, James W Dear
Mar 10, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·E MashiachB Kristal
Apr 1, 1977·The Journal of Pharmacy and Pharmacology·D HowieL F Prescott
Jan 1, 1981·The Journal of International Medical Research·A N HamlynP Crome
Oct 1, 1980·British Journal of Clinical Pharmacology·L F Prescott
Jun 24, 2015·British Journal of Clinical Pharmacology·D Nicholas Bateman
Sep 22, 2015·British Journal of Clinical Pharmacology·Angela L ChiewNicholas A Buckley
Sep 1, 1978·Hospital Practice·J R Mitchell, B H Lauterburg
Aug 1, 1984·British Journal of Clinical Pharmacology·I RobertsL F Prescott
Apr 1, 1995·AIDS Research and Human Retroviruses·W Z HoS D Douglas
Nov 17, 2010·International Journal of Cancer. Journal International Du Cancer·Xiao-Mei WanLong-Ping Wen
May 1, 1977·Anaesthesia·J A Vale
Mar 1, 1979·Annals of Clinical Biochemistry·M J StewartL F Prescott
Sep 1, 1979·Annals of Clinical Biochemistry·J Epton
Jun 28, 1980·The Medical Journal of Australia·T E Oh, G M Shenfield
Apr 8, 1978·The Medical Journal of Australia·R J RigbyT P Cheung

Related Concepts

Drug Evaluation
Liver Dysfunction
Drug-Induced Acute Liver Injury
Kidney Failure, Acute

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.